Cr/Crn Ratio, Mycostatin May Be Viable Biomarkers For Monitoring Functional Outcomes Among Patients With Becker Muscular Dystrophy, Researcher Say
January 13, 2023
Neurology Advisor (1/12, Nye) reports, “Creatine/creatinine ratio (Cr/Crn) and myostatin may be viable biomarkers for monitoring functional outcomes among patients with Becker muscular dystrophy,” researchers concluded in the findings of a 34-patient stud...